Citation Impact
Citing Papers
Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis
2015
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report
2016 StandoutNobel
Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis
2019
Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon
2017 Standout
Microbiota in health and diseases
2022 Standout
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
2011
Cytokines in inflammatory bowel disease
2014 Standout
Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues
2013
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Distinct Profiles of Effector Cytokines Mark the Different Phases of Crohn’s Disease
2013
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
2018
Immunopathology of inflammatory bowel disease
2014
NF-κB signaling in inflammation
2017 Standout
Rheumatoid arthritis
2018 Standout
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing
2014
Rheumatoid arthritis
2016 Standout
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
2014 Standout
The IL-17 Family of Cytokines in Health and Disease
2019
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Bayesian Design of Proof-of-Concept Trials
2014
Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease
2014
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
2017
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
2017
Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial
2019
The biology behind interleukin-6 targeted interventions
2016
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Psoriasis
2021 Standout
Epidemiology and risk factors for IBD
2015 Standout
Psoriasis: Which therapy for which patient
2018
The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells
2019
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Interaction between microbiota and immunity in health and disease
2020 Standout
Genetics of Inflammatory Bowel Diseases
2015
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Biomarkers in Search of Precision Medicine in IBD
2016
Innate and adaptive immunity in inflammatory bowel disease
2013
IL-6 as a keystone cytokine in health and disease
2015 Standout
Clinical management of psoriatic arthritis
2018
Molecular and cellular mechanisms of liver fibrosis and its regression
2020
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Commensal-Specific CD4+ Cells From Patients With Crohn’s Disease Have a T-Helper 17 Inflammatory Profile
2016
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
2015
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions
2015
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Crohn's disease
2016 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Targeting immune cell circuits and trafficking in inflammatory bowel disease
2019
Current understanding of the human microbiome
2018 Standout
Targeting Th17 cells in autoimmune diseases
2014
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Cytokines, IBD, and Colitis-associated Cancer
2015
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
2018 Standout
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
The dichotomous nature of T helper 17 cells
2017
Advances in IBD genetics
2014
Targeting IL-17 and TH17 cells in chronic inflammation
2012
Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
2015
IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
2015
Susceptibility to chronic inflammation: an update
2017
Inhibition of Dectin-1 Signaling Ameliorates Colitis by Inducing Lactobacillus-Mediated Regulatory T Cell Expansion in the Intestine
2015
10 Years of GWAS Discovery: Biology, Function, and Translation
2017 Standout
Emerging cell and cytokine targets in rheumatoid arthritis
2013
Ulcerative colitis
2020 Standout
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Innate lymphoid cells — a proposal for uniform nomenclature
2013 Standout
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
2015
Neutrophils in cancer: neutral no more
2016 Standout
How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
2013
New targets for mucosal healing and therapy in inflammatory bowel diseases
2013
Fibroblasts as immune regulators in infection, inflammation and cancer
2021
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Nontuberculous Mycobacteria Infections in Immunosuppressed Hosts
2014
Genetic insights into common pathways and complex relationships among immune-mediated diseases
2013
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Review article: novel oral‐targeted therapies in inflammatory bowel disease
2018
Ex-Th17 (Nonclassical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells
2017
Regulatory T Cells and Human Disease
2020 StandoutNobel
The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases
2013
Psoriasis Pathogenesis and Treatment
2019 Standout
Adaptive immune education by gut microbiota antigens
2018
Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice
2016 StandoutNobel
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity
2015
Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids
2014
CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22
2014
Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn’s disease
2018
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
2022 StandoutNobel
Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease
2018
The effects of the microbiota on the host immune system
2014
T-cell Composition in Ileal and Colonic Creeping Fat – Separating Ileal from Colonic Crohn’s Disease
2018
Interleukin 23 in Crohnʼs Disease
2014
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Role of Chlorogenic Acids in Controlling Oxidative and Inflammatory Stress Conditions
2015 Standout
Works of Marek Karczewski being referenced
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Bacterial Infections in Renal Transplant Recipients
2015
Cytometric analysis of TH1/TH2 cytokines in the urine of patients undergoing kidney transplantation.
2009